Rating Change
BTIG reiterated its Buy rating on CARLSMED, INC. (NASDAQ:CARL) on October 12, 2026.
BTIG reiterated its Buy rating on CARLSMED, INC. (NASDAQ:CARL) on October 12, 2026.

At publication ·
CARLSMED, INC. (NASDAQ:CARL) · reiterate
At a glance
BTIG reiterated its Buy rating on CARLSMED, INC. (NASDAQ:CARL) on October 12, 2026.
CARLSMED, INC. operates in the Healthcare sector. The stock currently trades at $14.78 with a market capitalization of $348.6M.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CARLSMED, INC.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 12, 2026 | BTIG | Buy | N/A |
| Sep 28, 2026 | BTIG | Buy | N/A |
| Aug 06, 2026 | Truist Securities | Buy | N/A |
| Jul 01, 2026 | Needham | Buy | N/A |
| May 06, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CARL Stock Page
A rating of Buy from BTIG reflects the analyst's outlook on CARLSMED, INC. (NASDAQ:CARL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CARL forecast page.
Current market data
NASDAQ · CARL
$14.53
Down: -$0.08 · -0.55%
Live quote updated
Keep reading